Granisetron HCl 2 mg Oral Tablet
RxNorm 250535
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 250535 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: granisetron HCl 2 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Granisetron 2 mg Oral Tablet
(Atom ID: 12339455)
PT
Designated preferred name (PT):
Granisetron (as granisetron hydrochloride) 2 mg oral tablet
(Atom ID: 10299368)
SY
Synonym (SY):
Granisetron 2 mg (granisetron hydrochloride 2.24 mg) Oral Tablet
(Atom ID: 3264220)
PSN
Prescribable Name (PSN):
Granisetron HCl 2 mg Oral Tablet
(Atom ID: 7739202)
FN
Full form of descriptor (FN):
Product containing precisely granisetron (as granisetron hydrochloride) 2 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10313129)
Patient Education
Granisetron
Granisetron is used to prevent nausea and vomiting caused by cancer chemotherapy and radiation therapy. Granisetron is in a class of medications called 5-HT3 receptor antagonists. It works by blocking serotonin, a natural substance in the body that causes nausea and vomiting.
[Learn More]
* Please review the disclaimer below.